Please check back soon.

Method Development and Qualification Considerations for Octet-Based Potency Assays
2017-Dec-05

10 AM ET
Nathan P. Oien, Ph.D., Senior Scientist, KBI Biopharma
Srilaxmi Sarikonda, M.S., Sr. Research Associate, KBI Biopharma

Asia: Method Development and Qualification Considerations for Octet-Based Potency Assays
2017-Dec-12

09:00 AM Singapore Time

Nathan P. Oien, Ph.D., Senior Scientist, KBI Biopharma
Srilaxmi Sarikonda, M.S., Sr. Research Associate, KBI Biopharma

<a href='https://www.fortebio.com/customer-spotlights.html'>OCTET SYSTEMS AT WORK</a>

OCTET SYSTEMS AT WORK

Octet system users are at the forefront of research across a range of applications. Read how real-world scientists are improving screening efficiency, increasing sample capacity and generating higher quality data. 

<a href='https://event.on24.com/wcc/r/1536435/5664D83BF1E18AA133AA1D73DBC4926F'>UPCOMING WEBINAR: IMPROVE YOUR POTENCY ASSAYS</a>

UPCOMING WEBINAR: IMPROVE YOUR POTENCY ASSAYS

KBI Biopharma developed a variety of Octet-based potency assays to accelerate their target to phase 1 clinical trials timeline. Important factors when developing these dual-binding assays will be discussed.

<a href='http://go.pall.com/PioneerFAQ.html'>NEXT-GEN SPR INTERACTIONS ANALYSIS</a>

NEXT-GEN SPR INTERACTIONS ANALYSIS

diSPR with Pioneer systems enables characterization of interactions that can’t be done with traditional SPR. Get affinity and kinetics data from primary screens, analyze unstable targets, assay a wider range of molecules and more.  

NEW!

Octet RED96e System

Discover the next big thing

Octet RED96e System

NEW! Octet RED96e System

12 hours of unattended run time.
Temperature control down
to 15 °C!

learn more